Inventors:
The United States of America, as represented by the Secretary, Department of Health and Human Service - , US
Vyomesh Patel - Washington DC, US
Ana p. Cotrim - Bethesda MD, US
Alfredo Molinolo - Rockville MD, US
James B. Mitchell - Damascus MD, US
International Classification:
A61K 31/436
Abstract:
Disclosed is a method of preventing the development of mucositis in a subject undergoing radiation therapy or chemotherapy for a disease in need thereof comprising administering an effective amount of a mammalian target of rapamycin (mTOR) inhibitor, such as rapamycin, to the subject. Further disclosed is a method of increasing the lifespan of a normal oral keratinocyte and/or reducing oxidative stress in a normal epithelial cell, wherein the method comprises administering an effective amount of an mTOR inhibitor to a subject undergoing radiation therapy or chemotherapy for a disease in need thereof.